Featured Research

from universities, journals, and other organizations

Younger Hispanic women face higher risk of death from heart attack

Date:
November 19, 2013
Source:
American Heart Association
Summary:
Younger Hispanic women face a higher risk of death in hospitals after a heart attack, are more likely to suffer from co-existing conditions such as diabetes, and are less likely to undergo percutaneous coronary interventions or coronary artery bypass surgery as compared with white women and men, according to research.

Younger Hispanic women face a higher risk of death in hospitals after a heart attack, are more likely to suffer from co-existing conditions such as diabetes, and are less likely to undergo percutaneous coronary interventions or coronary artery bypass surgery as compared with white women and men, according to research presented at the American Heart Association's Scientific Sessions 2013.

Researchers analyzed a large in-patient population of about 207,000 heart attack hospitalizations for adult men and women with race/ethnicity data, including more than 6,500 Hispanic and black women less than 65 years old. Hispanic and black women were significantly younger at the time of hospitalization for heart attack compared with their white counterparts.

Researchers found:

  • After adjusting for clinical and demographic characteristics, younger Hispanic, black and white women were 1.5, 1.4, and 1.2 times more likely, respectively to experience higher in-hospital death compared with white men.
  • Younger Hispanic women also suffered the highest rates of diabetes at 55.9 percent compared with 46.1 percent of black women and 35.9 percent of white women.
  • 47.4 percent black women, 50.1 percent of Hispanic women and 58.2 percent of white women had percutaneous coronary interventions or coronary artery bypass surgery compared to 73.3 percent of white men.

Doctors may not recognize risk factors and symptoms for young women suffering from ischemic heart disease and younger Hispanic women in particular, researchers said. Other factors include language barriers, lack of access to health care, provider bias and differences in treatment patterns.

"Our findings of striking racial/ethnic, gender and age disparities in heart attack treatment patterns and outcomes suggest that young minority women should be targeted for both primary and secondary prevention of ischemic heart disease," said Fatima Rodriguez, M.D., M.P.H., study leading author, Internal Medicine Resident at Brigham and Women's Hospital, Harvard Medical School in Boston, Mass.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Younger Hispanic women face higher risk of death from heart attack." ScienceDaily. ScienceDaily, 19 November 2013. <www.sciencedaily.com/releases/2013/11/131119193630.htm>.
American Heart Association. (2013, November 19). Younger Hispanic women face higher risk of death from heart attack. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/11/131119193630.htm
American Heart Association. "Younger Hispanic women face higher risk of death from heart attack." ScienceDaily. www.sciencedaily.com/releases/2013/11/131119193630.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins